Susan Rehm

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. doi request reprint Identifying barriers to adult pneumococcal vaccination: an NFID task force meeting
    Susan J Rehm
    Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH 44195, USA
    Postgrad Med 124:71-9. 2012
  2. doi request reprint Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus
    Susan J Rehm
    Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Clin Infect Dis 51:S176-82. 2010
  3. doi request reprint Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults
    Susan J Rehm
    National Foundation for Infectious Diseases, Bethesda, MD, USA
    Postgrad Med 121:101-5. 2009
  4. pmc Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy
    Susan Rehm
    Department of Infectious Diseases, Cleveland Clinic, OH 44195, USA
    J Antimicrob Chemother 63:1034-42. 2009
  5. ncbi request reprint Staphylococcus aureus: the new adventures of a legendary pathogen
    Susan J Rehm
    Department of Infectious Disease, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 75:177-80, 183-6, 190-2. 2008
  6. ncbi request reprint Successful administration of quinupristin/dalfopristin in the outpatient setting
    S J Rehm
    Department of Infectious Disease, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Antimicrob Chemother 47:639-45. 2001
  7. ncbi request reprint The far-reaching impact of antimicrobial resistance
    Susan J Rehm
    Cleveland Clinic, Cleveland, Ohio 44195, USA
    Clin Infect Dis 45:S97-8. 2007
  8. ncbi request reprint Challenges in the management of serious infections
    Susan J Rehm
    Department of Infectious Disease, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Clin Infect Dis 42:S63-4. 2006
  9. ncbi request reprint Two new treatment options for infections due to drug-resistant gram-positive cocci
    Susan J Rehm
    Department of Infectious Diseases, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 69:397-401, 405-13. 2002
  10. ncbi request reprint Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients
    DeRen Huang
    Department of Neurology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Ann Neurol 62:34-9. 2007

Detail Information

Publications18

  1. doi request reprint Identifying barriers to adult pneumococcal vaccination: an NFID task force meeting
    Susan J Rehm
    Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH 44195, USA
    Postgrad Med 124:71-9. 2012
    ..All health care providers need to accept responsibility for vaccination so that this preventive measure becomes a high priority in the care of patients at risk for serious pneumococcal infection...
  2. doi request reprint Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus
    Susan J Rehm
    Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Clin Infect Dis 51:S176-82. 2010
    ..Several strategies to reduce the nosocomial burden of resistance are suggested, including shortened hospital stays and outpatient parenteral antimicrobial therapy of the most serious infections...
  3. doi request reprint Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults
    Susan J Rehm
    National Foundation for Infectious Diseases, Bethesda, MD, USA
    Postgrad Med 121:101-5. 2009
    ....
  4. pmc Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy
    Susan Rehm
    Department of Infectious Diseases, Cleveland Clinic, OH 44195, USA
    J Antimicrob Chemother 63:1034-42. 2009
    ..Administering outpatient parenteral antimicrobial therapy in the community setting (CoPAT) is becoming more common with the increasing emphasis on controlling costs. However, few controlled trials have evaluated this treatment modality...
  5. ncbi request reprint Staphylococcus aureus: the new adventures of a legendary pathogen
    Susan J Rehm
    Department of Infectious Disease, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 75:177-80, 183-6, 190-2. 2008
    ..Another worrisome trend is increasing resistance to vancomycin (Vancocin)...
  6. ncbi request reprint Successful administration of quinupristin/dalfopristin in the outpatient setting
    S J Rehm
    Department of Infectious Disease, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Antimicrob Chemother 47:639-45. 2001
    ..In this group of patients, for those who had difficult-to-treat infections, intravenous quinupristin/dalfopristin therapy was generally effective and safe outside the hospital setting...
  7. ncbi request reprint The far-reaching impact of antimicrobial resistance
    Susan J Rehm
    Cleveland Clinic, Cleveland, Ohio 44195, USA
    Clin Infect Dis 45:S97-8. 2007
  8. ncbi request reprint Challenges in the management of serious infections
    Susan J Rehm
    Department of Infectious Disease, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Clin Infect Dis 42:S63-4. 2006
  9. ncbi request reprint Two new treatment options for infections due to drug-resistant gram-positive cocci
    Susan J Rehm
    Department of Infectious Diseases, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 69:397-401, 405-13. 2002
    ..But their use must be tempered by their cost, toxicity, and concerns about further development of resistant strains...
  10. ncbi request reprint Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients
    DeRen Huang
    Department of Neurology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Ann Neurol 62:34-9. 2007
    ..MRI diagnostic criteria for PML suggest that iPML does not occur in HIV-negative individuals...
  11. doi request reprint Transitioning antimicrobial stewardship beyond the hospital: the Cleveland Clinic's community-based parenteral anti-infective therapy (CoPAT) program
    Steven M Gordon
    Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Hosp Med 6:S24-30. 2011
    ....
  12. pmc Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates
    Susan J Rehm
    Cleveland Clinic, Cleveland, OH, USA
    J Antimicrob Chemother 62:1413-21. 2008
    ..aureus bacteraemia, clinical characteristics and treatment results in the trial's pre-specified subset of patients with MRSA were analysed...
  13. ncbi request reprint Arterial infection and staphylococcus aureus bacteremia after transfemoral cannulation for percutaneous carotid angioplasty and stenting
    Daniel A Culver
    Internal Medicine Residency Program, The Cleveland Clinic Foundation, Ohio 44195, USA
    J Vasc Surg 35:576-9. 2002
    ....
  14. ncbi request reprint Deep sternal wire infection resulting in severe pulmonary valve endocarditis
    Sekar S Bhavani
    Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Ann Thorac Surg 82:1111-3. 2006
    ....
  15. doi request reprint Vancomycin: a 50-something-year-old antibiotic we still don't understand
    Amy Schilling
    Department of Infectious Disease, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Cleve Clin J Med 78:465-71. 2011
    ..For clinicians, it is vital to remain up-to-date with evolving definitions for vancomycin susceptibility, with new interpretations of efficacy, and with information on toxicity...
  16. ncbi request reprint Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
    Vance G Fowler
    Duke University Medical Center, Durham, NC 27710, USA
    N Engl J Med 355:653-65. 2006
    ..Alternative therapies for Staphylococcus aureus bacteremia and endocarditis are needed...
  17. ncbi request reprint Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines
    Alan D Tice
    John A Burns School of Medicine, University of Hawaii, Honolulu, HI 96813, USA
    Clin Infect Dis 38:1651-72. 2004
  18. ncbi request reprint Infections in hospitalized patients: what is happening and who can help?
    Alpesh N Amin
    Hospitalist Program, University of California, Irvine, Orange, CA 92868, USA
    Cleve Clin J Med 74:S2-5. 2007
    ..Such collaboration can potentially reduce treatment failures and minimize the spread of multidrug-resistant organisms between health care settings and the community...